focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

Thu, 09th Nov 2023 12:06

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

The FTSE 100 index was up 25.06 points, 0.3%, at 7,426.78. The FTSE 250 was up 79.72 points, 0.5%, at 17,925.98, and the AIM All-Share was up 2.01 points, 0.3%, at 703.69.

The Cboe UK 100 was up 0.3% at 741.32, the Cboe UK 250 was up 0.4% at 15,555.44, and the Cboe Small Companies was down 0.1% at 12,911.41.

In European equities, the CAC 40 in Paris was up 0.6%, while the DAX 40 in Frankfurt was up 0.4%.

The US Federal Reserve is likely done raising interest rates to tackle inflation but probably will not cut them "in the short term," a senior policymaker said Wednesday.

Philadelphia Fed President Patrick Harker told a conference in Evanston, Illinois, that he felt holding interest rates at their current, restrictive, level was the right course of action.

Harker spoke after remarks from Fed Chair Powell. Investors were hoping for some guidance from Powell on Wednesday, but he gave little away about interest rates. He did not comment on the outlook for the US economy, either.

"While hopes have risen recently that cuts will be on the horizon sooner rather than later next year, it is clear that the Fed will be driven by the data, and no definite path has been set," said Hargreaves Lansdown analyst Susannah Streeter.

Powell speaks again at 1900 GMT on Thursday. Also still to come on Thursday is the latest US jobless claims reading at 1330 GMT.

Stocks in New York were called to open mixed. The Dow Jones Industrial Average was called up 0.2%, the S&P 500 index up 0.1%, but the Nasdaq Composite down 0.1%.

The pound traded at USD1.2258 on Thursday midday, down from USD1.2300 at the time of the London equities close on Wednesday. The euro was down at USD1.0684 from USD1.0707. Against the yen, the greenback climbed to JPY151.17 from JPY150.83.

China slipped back into deflation in October, highlighting the work officials have in reviving still-sluggish demand in the world's number two economy.

The consumer price index, the main gauge of inflation, fell 0.2% on-year, according to the National Bureau of Statistics. The index had been unchanged year-on-year in September and edged up 0.1% in August.

A poor demand outlook weighed on oil prices, meanwhile, which have fallen recently amid no supply disruptions being seen in the Middle East, despite the war between Israel and Hamas.

A barrel of Brent Crude fetched USD79.97 on Thursday at midday, down from USD80.05 at the time of the European equities close on Wednesday.

There was also a slew of updates which gave a mixed view of the health of London-listed corporates.

"A mixed bag is putting it lightly. Plenty of companies are finding they cannot meet market expectations and so we're seeing some chunky one-day share price declines," said AJ Bell analyst Russ Mould.

In the FTSE 100, Flutter Entertainment shares led losses by dropping 8.8%, with the Paddy Power owner's outlook disappointing as the firm grapples with punter-friendly sports results.

It now expects US revenue of GBP3.75 billion, around the middle of its previous GBP3.6 billion to GBP3.9 billion range. US adjusted earnings before interest, tax, depreciation and amortisation of GBP140 million are expected, around the middle of its GBP90 million to GBP190 million range. Excluding the US, it expects group revenue at the bottom of its GBP1.44 billion to GBP1.6 billion range.

Total revenue in the third-quarter of 2023 was 7.6% higher at GBP2.04 billion from GBP1.89 billion a year prior.

Looking to next year, Flutter expects to list on the New York Stock Exchange in the first quarter of 2024. It will delist from Euronext Dublin "simultaneously or shortly prior to this".

B&M lost 3.5%, despite the retailer saying revenue in the half-year to September 23 rose 10% to GBP2.55 billion from GBP2.31 billion.

Pretax profit grew 11% to GBP222 million from GBP201 million, while it lifted its ordinary dividend by 2.0% to 5.1 pence from 5.0p.

Peel Hunt analysts said B&M start to the Christmas period has been "satisfactory without being eye-catching".

Auto Trader fared much better, leading the FTSE 100 with a 7.7% rise. Revenue in the automotive marketplace's first-half ended September 30 rose 12% to GBP280.5 million from GBP249.8 million. Its pretax profit was 10% higher at GBP162.8 million from GBP148.0 million.

AstraZeneca rose 2.8%, as it lifted guidance, posted a better third-quarter and announced a deal in the burgeoning weight loss drug space.

Total revenue in the third quarter of 2023 rose 4.6% on-year to USD11.49 billion from USD10.98 billion. Pretax profit was 79% higher at USD1.65 billion from USD922 million, the drugmaker said.

AstraZeneca reported core earnings per share growth of 4% to US1.73. It now expects full-year core EPS growth in the "low double-digit to low-teens percentage" range at constant currency. It had previously predicted "high single-digit to low double-digit percentage" growth.

AstraZeneca said it has also landed a pact focused on an obesity drug, agreeing a licence deal for ECC5004 with biopharmaceutical firm Eccogene.

Eccogene gets USD185 million upfront and could receive an additional USD1.83 billion in future "clinical, regulatory, and commercial milestones and tiered royalties on product net sales".

"While this might be perceived as an attempt to jump on the coat tails of the likes of Novo Nordisk and Eli Lilly in what has become a booming market, AstraZeneca has form for adding strings to its bow – prior to the Covid pandemic it was not considered to have any particular expertise in vaccines, for example," said AJ Bell's Mould.

"The latest update will build confidence the company can sustain its recent momentum and reclaim its position as the largest company on the FTSE 100 from energy giant Shell."

In the FTSE 250, Lancashire Holdings rose 6.9%, after it reported 23% year-on-year growth in gross premiums written to USD1.56 billion for the nine months to September 30, alongside announcing a capital return of up to USD169 million. This would be via a USD119 million special dividend and a USD50 million share buyback.

It also added Philip Broadley as a non-executive director and chair designate. Broadley is expected to take on the chair role following the firm's 2024 annual general meeting. He is currently a non-exec at Legal & General and senior independent director at AstraZeneca, roles he is expected to continue.

Domino's Pizza Group fell 7.4%, after the UK franchise of the wider US pizza chain reported like-for-like sales grew more than 3.7% in the third quarter, while its total sales increased 5.5%.

However, total orders fell 1.2% in the quarter to 16.2 million despite being up 1.5% overall in the year-to-date.

Chief Executive Andrew Rennie said: "Our franchisees are performing well in an uncertain market, and we are all benefitting from an aligned system....As we look into next year, we see inflation stabilising and our focus will be on continued customer and order growth, as well as franchisee profitability."

Among the small-caps, STV shares hit a 52-week low on Thursday. It went into the afternoon 5.9% lower.

The television broadcaster and content producer said it expects annual operating profit of GBP20 million in 2023, hurt by "weak national TV advertising in [the fourth quarter] and the related effect on the rate of commissioning in Studios". This would be down from the GBP25.3 million achieved in 2022.

Gold faded to USD1,948.20 an ounce on Thursday midday in London, from USD1,954.55 at the time of the European equities close on Wednesday.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.